TAVI in New Zealand; A cost effective treatment for patients with aortic stenosis at high surgical risk?
The costs of TAVI when compared to SAVR in a New Zealand setting are unknown.
D. Smyth, J. Blake, R. Troughton, M. Hart, G. Roper, D. Williams, H. Singh
Christchurch Hospital, Christchurch
Heart, Lung and Circulation – Volume 23, Supplement 1, e1-e48
Abstract & full-text available.
Resource Library Item
This resource is available for registered members of CSANZ.
Click the button below to log in to HeartOne and access this resource. Please note that CPD credit is NOT automatically assigned for accessing resources directly.